JD Health International Inc.
JDHIY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $58,159,881 | $53,529,941 | $46,736,150 | $30,682,267 |
| % Growth | 8.6% | 14.5% | 52.3% | – |
| Cost of Goods Sold | $44,851,304 | $41,664,605 | $36,844,642 | $23,484,985 |
| Gross Profit | $13,308,577 | $11,865,336 | $9,891,508 | $7,197,282 |
| % Margin | 22.9% | 22.2% | 21.2% | 23.5% |
| R&D Expenses | $1,330,435 | $1,226,494 | $1,067,174 | $892,913 |
| G&A Expenses | $1,419,040 | $1,998,376 | $2,153,529 | $5,536,221 |
| SG&A Expenses | $4,467,771 | $4,653,349 | $4,349,293 | $7,670,062 |
| Sales & Mktg Exp. | $3,048,731 | $2,654,973 | $2,195,764 | $2,133,841 |
| Other Operating Expenses | $6,031,607 | $0 | $82,521 | $0 |
| Operating Expenses | $11,829,813 | $11,234,488 | $9,938,426 | $8,562,975 |
| Operating Income | $1,478,764 | $630,848 | $803,110 | -$857,140 |
| % Margin | 2.5% | 1.2% | 1.7% | -2.8% |
| Other Income/Exp. Net | $3,317,912 | $2,062,500 | $840,929 | -$44,351 |
| Pre-Tax Income | $4,796,676 | $2,693,348 | $695,809 | -$901,491 |
| Tax Expense | $639,662 | $550,468 | $312,580 | $171,327 |
| Net Income | $4,161,844 | $2,141,841 | $380,105 | -$1,073,507 |
| % Margin | 7.2% | 4% | 0.8% | -3.5% |
| EPS | 1.32 | 0.69 | 0.12 | -0.35 |
| % Growth | 91.3% | 475% | 134.3% | – |
| EPS Diluted | 1.32 | 0.68 | 0.12 | -0.35 |
| Weighted Avg Shares Out | 3,139,952 | 3,123,736 | 3,106,937 | 3,094,893 |
| Weighted Avg Shares Out Dil | 3,155,701 | 3,163,985 | 3,144,376 | 3,094,893 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,960,502 | $1,949,032 | $864,266 | $457,569 |
| Interest Expense | $8,194 | $9,485 | $9,099 | $5,999 |
| Depreciation & Amortization | $214,695 | $227,458 | $140,676 | $63,169 |
| EBITDA | $5,019,565 | $858,306 | $943,786 | -$832,323 |
| % Margin | 8.6% | 1.6% | 2% | -2.7% |